Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

Sherko Kümmel, J. Krocker, A. Kohls, +5

British Journal of Cancer

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

Peter Schmid, J. Krocker, C. Jehn, +12

Annals of Oncology

Breast OncologyEarly Breast CancerMedicinePharmacologyBreast Cancer +7

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

Peter A. Fasching, Sebastian M. Jud, Maik Hauschild, +20

BMC Cancer

Detection ofBRCA1 andBRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure

E. Spitzer, Mohammad Reza Abbaszadegan, Frank Schmidt, +7

International Journal of Cancer

Breast OncologyOncologySomatic VariantTumor HeterogeneityMedicine +10

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

Sherko Küemmel, J. Krocker, A. Kohls, +7

Journal of Clinical Oncology

Breast OncologyElderly PatientsCancer ManagementPharmacotherapyMetronomic Chemotherapy +17

Intraductal component in invasive breast cancer: analysis of 250 resected surgical specimens

Dirk Elling, Anne‐Sophie Vesper, B. Fiedler, +2

The Breast

Resected Surgical SpecimensSurgical OncologySitu ComponentsInvasive CarcinomaInvasive Breast Cancer +12

Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial

Peter Schmid, J. Krocker, Carsten‐Oliver Schulz, +8

Anti-Cancer Drugs

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial

Peter Schmid, J. Krocker, R. Kreienberg, +8

Cancer Chemotherapy and Pharmacology

Final ResultsMetastatic Breast CancerBreast OncologyMedicinePharmacology +7

Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: Feasibility and tolerability in a subset of patients in a randomized trial

Sherko Kümmel, J. Krocker, A. Kohls, +6

Critical Reviews in Oncology/Hematology

Breast OncologyOncologyWomen 60Breast CancerRandomized Trial +4